References

Parkinson’s disease

10.1016/s0140-6736(14)61393-3 · 2015 · External reference

The prevalence of parkinson’s disease: a systematic review and meta-analyis

10.1002/mds.25945 · 2014 · External reference

The Parkinson pandemic-a call to action

10.1001/jamaneurol.2017.3299 · 2018 · External reference

Progression of moter symptoms in Parkinson’s disease

10.1007/s12264-012-1050-z · 2012 · External reference

Oxidative stress and regulated cell death in Parkinson’s disease

10.1016/j.arr.2021.101263 · 2021 · External reference

Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions

10.1038/s41392-023-01353-3 · 2023 · External reference

Oxidative stress, mitochondria dysfunction and neurodegenerative disease; a mechanistic insight

10.1016/j.biopha.2015.07.025 · 2015 · External reference

Oxidative stress sensor keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

10.1128/mcb.24.16.7130-7139.2004 · 2004 · External reference

Direct evidence that sulfhydryl groups of Keaor1 are sensor regulating induction of phase 2 enzymes that protect against and carcinogens oxidants

10.1073/pnas.172398899 · 2002 · External reference

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

10.1101/gad.13.1.76 · 1999 · External reference

62-Nrf2-p62 mitophagy regulatory loop as a target for preventive therapy of neurodegenerative diseases

10.3390/brainsci10110847 · 2020 · External reference

p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription

10.1074/jbc.m110.118976 · 2010 · External reference

Rotenone-induced model of Parkinson’s disease: beyond mitochondrial complex I inhibition

10.1007/s12035-022-03193-8 · 2023 · External reference

Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production

10.1074/jbc.m210432200 · 2003 · External reference

Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection

10.4061/2011/617472 · 2010 · External reference

Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone

10.1111/j.1471-4159.2006.04440.x · 2007 · External reference

Gut–brain and brain–gut axis in Parkinson’s disease models: Effects of a uridine and fish oil diet

10.1080/1028415x.2017.1294555 · 2018 · External reference

A flavonoid-rich extract of mandarin juice counteracts 6-OHDA-induced oxidative stress in SH-SY5Y cells and modulates Parkinson-related genes

10.3390/antiox10040539 · 2021 · External reference

Strawberry Fragaria x ananssa cv. Festival: a polyphenol-based phytochemical characterization in fruit and leaf extracts

10.3390/molecules28041865 · 2023 · External reference

Non-targeted metabolite profiling highlights the potential of strawberry leaves as a resource for specific bioactive compounds

10.1002/jsfa.8027 · 2017 · External reference

Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage

10.1021/jf9908345 · 2000 · External reference

Strawberry leaf extract treatment alleviates cognitive impairment by activating Nrf2/HO-1 signaling in rats with streptozotocin-induced diabetes

10.3389/fnagi.2020.00201 · 2020 · External reference

Maximizing the recovery of phenolic antioxidants from wild strawberry (Fragaria vesca) leaves using microwave-assisted extraction and accelerated solvent extraction

10.3390/pr11123378 · 2023 · External reference

Ecklonia cava polyphenols have a preventive effect on Parkinson’ s disease through the activation of the Nrf2-ARE pathway

10.3390/nu16132076 · 2024 · External reference

Pharmacological modulation of Nrf2/HO-1 signaling pathway as a therapeutic target of Parkinson’s disease

10.3389/fphar.2021.757161 · 2021 · External reference

Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival

10.1152/ajpheart.00749.2010 · 2010 · External reference

Chronic systemic pesticide exposure reproduces features of Parkinson’s disease

10.1038/81834 · 2000 · External reference

Mechanism of toxicity in rotenone models of Parkinson’s disease

10.1523/jneurosci.23-34-10756.2003 · 2007 · External reference

The role of oxidative stress in Parkinson’s disease

10.3233/jpd-130230 · 2013 · External reference

Slowing of neurodegeneration in Parkinson’s disease and Huntington’s disease: future therapeutic perspectives

10.1016/s0140-6736(14)61010-2 · 2014 · External reference

Role of Nrf2 in oxidative stress and toxicity

10.1146/annurev-pharmtox-011112-140320 · 2013 · External reference

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathways

10.1146/annurev.pharmtox.46.120604.141046 · 2007 · External reference

The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1

10.1038/ncb2021 · 2010 · External reference

AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550

10.1128/mcb.00118-16 · 2016 · External reference

AMPK leaalian ds to phosphorylation of transcription factor Nrf2, tuning transactivation of selected target genes

10.1016/j.redox.2019.101393 · 2020 · External reference

The role of PINK1, Parkin, and mitochondrial fidelity in Parkinson’s disease

10.1016/j.neuron.2014.12.007 · 2015 · External reference

Autophagy in mammalian development and differentiation

10.1038/ncb0910-823 · 2010 · External reference

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

10.1083/jcb.200809125 · 2008 · External reference

The role of mitochondria in apoptosis

10.1146/annurev-genet-102108-134850 · 2009 · External reference

A highly reproducible rotenone model of Parkinson’s disease

10.1016/j.nbd.2009.01.016 · 2009 · External reference

An update on the rotenone models of Parkinson’s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions

10.1016/j.neuro.2014.12.002 · 2015 · External reference

Flvonoids: modulators of brain function?

10.1017/s0007114508965776 · 2008 · External reference

Flavonoid permeability across an in situ model of the blood-brain barrier

10.1016/j.freeradbiomed.2003.11.023 · 2004 · External reference

Dietary polyphenols and the prevention of diseases

10.1080/1040869059096 · 2005 · External reference

Flavonoids: antioxidants or signalling molecules?

10.1016/j.freeradbiomed.2004.01.001 · 2004 · External reference